Insider: BATE KENNETH Director - MADRIGAL PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 10,310 | 0 | 10,310 |
| Value | $5,638,435.90 | $0.00 | $5,638,435.90 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/15/2025 | DDS | 2,317 | Direct | COM | $363.41 | $842,014.48 | 10,310 |
| 08/15/2025 | DDS | 896 | Direct | COM | $368.56 | $330,225.91 | 2,627 |
| 08/15/2025 | DDS | 2,567 | Direct | COM | $365.33 | $937,792.87 | 5,227 |
| 08/15/2025 | DDS | 2,516 | Direct | COM | $364.24 | $916,427.59 | 7,794 |
| 08/15/2025 | DDS | 1,104 | Direct | COM | $367.63 | $405,864.73 | 3,523 |
| 08/15/2025 | DDS | 600 | Direct | COM | $366.14 | $219,682.98 | 4,627 |
| 04/02/2024 | DDS | 2,080 | Direct | COM | $244.97 | $509,527.20 | 2,065 |
| 04/02/2024 | DDS | 1,217 | Direct | COM | $243.28 | $296,074.56 | 11,193 |
| 04/02/2024 | DDS | 567 | Direct | COM | $246.20 | $139,596.99 | 1,498 |
| 04/02/2024 | DDS | 7,048 | Direct | COM | $244.27 | $1,721,630.47 | 4,145 |
| 04/02/2024 | DDS | 100 | Direct | COM | $246.88 | $24,688.05 | 1,398 |
| 04/02/2024 | DDS | 7 | Direct | COM | $249.05 | $1,743.35 | 1,198 |
| 04/02/2024 | DDS | 193 | Direct | COM | $248.49 | $47,958.32 | 1,205 |
| 04/01/2024 | DDS | 2,104 | Direct | COM | $258.24 | $543,339.48 | 3,472 |
| 04/01/2024 | DDS | 2,790 | Direct | COM | $257.33 | $717,940.10 | 5,576 |
| 04/01/2024 | DDS | 6,698 | Direct | COM | $255.62 | $1,712,119.32 | 15,777 |
| 04/01/2024 | DDS | 200 | Direct | COM | $259.13 | $51,826.00 | 3,272 |
| 04/01/2024 | DDS | 7,411 | Direct | COM | $256.49 | $1,900,850.35 | 8,366 |
| 04/01/2024 | DDS | 143 | Direct | COM | $263.08 | $37,620.67 | 2,288 |
| 04/01/2024 | DDS | 274 | Direct | COM | $266.91 | $73,132.02 | 1,198 |
| 04/01/2024 | DDS | 700 | Direct | COM | $265.36 | $185,748.99 | 1,472 |
| 04/01/2024 | DDS | 116 | Direct | COM | $264.73 | $30,709.18 | 2,172 |
| 04/01/2024 | DDS | 841 | Direct | COM | $262.18 | $220,493.13 | 2,431 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research